In this section
@article{Savage:2006:10.1038/ncpendmet0195,
author = {Savage, MO and Attie, KM and David, A and Metherell, LA and Clark, AJL and Camacho-Hübner, C},
doi = {10.1038/ncpendmet0195},
journal = {Nat Clin Pract Endocrinol Metab},
pages = {395--407},
title = {Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.},
url = {http://dx.doi.org/10.1038/ncpendmet0195},
volume = {2},
year = {2006}
}
TY - JOUR
AB - Advances in the diagnosis and treatment of growth hormone insensitivity disorders have occurred in the past 15 years. We discuss the current status of endocrine and molecular evaluation, focusing on the pediatric age range. All the identified mutations of the growth hormone receptor are included. Treatment with recombinant human insulin-like growth factor (rhIGF) 1 in classical cases is summarized and new targets for treatment are discussed, together with therapy using the complex formed between rhIGF1 and rhIGF-binding protein 3.
AU - Savage,MO
AU - Attie,KM
AU - David,A
AU - Metherell,LA
AU - Clark,AJL
AU - Camacho-Hübner,C
DO - 10.1038/ncpendmet0195
EP - 407
PY - 2006///
SN - 1745-8366
SP - 395
TI - Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
T2 - Nat Clin Pract Endocrinol Metab
UR - http://dx.doi.org/10.1038/ncpendmet0195
UR - https://www.ncbi.nlm.nih.gov/pubmed/16932322
VL - 2
ER -
Interested in studying a PhD at the Department of Life Sciences? Find out more about postgraduate research opportunties.